PI3K/AKT pathway is one of the most important mechanisms regulating cell proliferation and differentiation, which is often over-activated in cancers, and anti-cancer strategies based on PI3K inhibitors have been widely studied and have shown good prospects (Belli et al., 2023). This evidence concerns the gene AKT1 and cancer.